Convergent somatic mutations in metabolism genes in chronic liver disease.

Saved in:
Bibliographic Details
Title: Convergent somatic mutations in metabolism genes in chronic liver disease.
Authors: Ng SWK; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Rouhani FJ; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK.; Department of Surgery, Addenbrooke's Hospital, Cambridge, UK., Brunner SF; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Brzozowska N; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Aitken SJ; CRUK Cambridge Institute, Cambridge, UK.; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK.; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Yang M; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Abascal F; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Moore L; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Nikitopoulou E; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Chappell L; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Leongamornlert D; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Ivovic A; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Robinson P; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Butler T; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Sanders MA; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK.; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Williams N; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Coorens THH; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Teague J; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Raine K; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Butler AP; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Hooks Y; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Wilson B; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Birtchnell N; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Naylor H; Department of Surgery, Addenbrooke's Hospital, Cambridge, UK., Davies SE; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK., Stratton MR; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Martincorena I; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Rahbari R; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK., Frezza C; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Hoare M; CRUK Cambridge Institute, Cambridge, UK. Matthew.Hoare@cruk.cam.ac.uk.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Matthew.Hoare@cruk.cam.ac.uk., Campbell PJ; Cancer Genome Project, Wellcome Sanger Institute, Hinxton, UK. pc8@sanger.ac.uk.; Stem Cell Institute, University of Cambridge, Cambridge, UK. pc8@sanger.ac.uk.
Source: Nature [Nature] 2021 Oct; Vol. 598 (7881), pp. 473-478. Date of Electronic Publication: 2021 Oct 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-021-03974-6